| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005945 | Clinical Therapeutics | 2005 | 13 Pages |
Abstract
Although some clinical evidence supportsthe use of LHRH analogues as adjuvant or neoadjuvant therapy or following biochemical failure, further study is needed. In the meantime, clinicians should carefully weigh the potential benefits and risks of early hormone therapy when making treatment decisions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Teillac, MD Bono, MD Irani, MD Wirth, MD Zlotta,